ロード中...

Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology

Historically, patients with metastatic, persistent or recurrent cervical cancer had limited therapeutic options. Despite several Phase II/III clinical trials, the combination of cisplatin and paclitaxel remained the most effective chemotherapeutic regimen. In 2014, publication of Gynecologic Oncolog...

詳細記述

保存先:
書誌詳細
出版年:Future Oncol
主要な著者: Eskander, Ramez N, Tewari, Krishnansu S
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5613942/
https://ncbi.nlm.nih.gov/pubmed/25760973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.14.276
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!